Home / Cisatracurium / United States
US ATC M03AC11 · updated 2 Nov 2026
Cisatracurium shortage in United States
Is there a Cisatracurium shortage in United States?
Yes. As of 2 Nov 2026, 3 Cisatracurium products are reported short in United States, the first since 6 May 2026. No return date has been given. Main reason: not stated.
Also short in Germany, Italy, Spain, Ireland, Czechia. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Cisatracurium Besylate, Injection, 20 mg/10 mL (2 mg/mL) Multidose Vial (NDC 0409-1208-01) discontinuation | Hospira, Inc., a Pfizer Company | 6 May 2026 | not given | Not stated |
| US | Cisatracurium Besylate, Injection, 200 mg/20ml (10 mg/mL) Single Dose Vial (NDC 0409-1103-01) discontinuation | Hospira, Inc., a Pfizer Company | 6 May 2026 | not given | Not stated |
| US | Cisatracurium Besylate, Injection, 10 mg/5ml (2 mg/mL) Single Dose Vial (NDC 0409-1098-02) discontinuation | Hospira, Inc., a Pfizer Company | 11 Sep 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).